|
FDA Advisers Urge Regional Reporting of Adverse Events
The FDA should improve its adverse event reporting system (AERS) by creating regional reporting centers, focusing resources on more promising data sets and requiring mandatory reporting by physicians, FDA drug safety advisers recently recommended. This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives